Biopharma developing small-molecule mitophagy inducers.
| Date | Round | Amount |
|---|---|---|
| Aug 2024 | Series A Vandria, a Lausanne mitophagy biopharma, raised a $30.7M Series A with Hevolution Foundation and Dolby Family Ventures joining lead investor ND Capital. | $30.7M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.